Guidance
Oct 27, 2023

Other Reportable Information or Occurrence (ORIO)

Investigators sometimes receive information that has a direct impact on a research study. This information is reportable to the IRBMED . Frequently this information falls within the Adverse Event Reporting context, or it is reported to IRBMED in...
Guidance
Aug 14, 2023

Secondary Use research

Secondary Use research is subject to IRB oversight if investigators "obtain identifiable private data or identifiable biospecimens.” This is because the regulatory definition of “human subjects research” is met whenever an investigator obtains, uses...
Tags: MiChart Data Use Biorepository Use
Guidance
Aug 10, 2023

Reporting Time-Sensitive Modifications

NOTE: The following guidance does not apply to studies where IRBMED is relying on an external IRB for regulatory oversight ("ceding" IRB oversight). If your study is ceded, you must reach out to the IRB of Record for guidance and then submit an...
Guidance
Jul 12, 2023

Evaluating Risks to Participants

In human research studies, the IRBs are responsible for evaluating the risks, weighing the probability of each risk coming to pass, and assessing the magnitude of harm that may result. It must then judge whether the anticipated benefit – e.g.,...
Tags: U-M resource
Guidance
Apr 7, 2023

Retention of Research Data/Biospecimens

This document provides guidance on completing the IRB application and the informed consent document(s) for IRBMED applications (under IRBMED oversight) that are planning to collect data/biospecimens directly from research participants with an...
Policies
May 18, 2022

Statement of Practice: PEERRS Certification Requirements

This document replaces the March 11, 2019 "PEERRS Certification Requirements" document. Note: It is the responsibility of the PI to enforce appropriate human subjects protection education for study team roles where certification is not otherwise...
Guidance
Feb 26, 2021

Elements and Uses of a Repository

A research repository is defined as a collection of data/biospecimens that have been collected and stored with the intention of using the materials for future research , either by the investigator who collected them or by sharing the materials with...
Guidance
Aug 31, 2020

Certification Preparatory to Research

Review of data and/or biospecimens preparatory to research are not regulated under the Common Rule if any data obtained is not used for future research. However, if you or any member of the study team will be accessing Protected Health Information (...
Guidance
Aug 10, 2020

Decedents

Research involving data and/or biospecimens from decedents (deceased i ndividuals) is not regulated under the Common Rule. However, if you or any member of the study team will be accessing Protected Health Information (PHI) of the decedent(s), the...
Guidance
Aug 10, 2020

Limited Data Sets

Research on coded private information , or on non-identifiable information, is not regulated under the Common Rule . However, HIPAA Privacy Rule protections apply if a coded or non-identifiable data set contains Protected Health Information (PHI) in...
Guidance
Jul 22, 2020

Study-Specific Adverse Event (AE) Reporting Plans

The IRBMED Standard Adverse Event (AE) Reporting Timetable is designed to accommodate a wide range of study designs and risk levels. These standard guidelines apply only to IRBMED reporting; they do not apply to reporting that may be required by...

Pages